BRD2 and polycystic ovary syndrome: In this patient cohort, the five high-risk groups were compared for age, BMI, number of cases of polycystic ovary syndrome (PCOS), duration of infertility, baseline follicle-stimulating hormone (FSH), E2, duration of Gn stimulation, and Gn dose received by the patients.